Point-of-care (POC) diagnostics are used across care settings, from consumers’ homes to bedsides in hospital intensive care units. The point-of-care diagnostic industry marks the shift from curative to predictive medicine, and globally millions of dollars are spent annually on the market. Point-of-care diagnostics represent the middle ground between rapid testing performed near a patient that is low in complexity, and the advanced technology that uses clinical molecular diagnostics. To this end, point-of-care diagnostics seek rapid results with an ease-of-use operation. This collection of reports provides insight into the point-of-care diagnostics market’s developments, like its targeting of infectious diseases as initial objectives. Kalorama Information has routinely profiled the clinical POC diagnostics market in its product development trends, market opportunities, and current and future sales in several product categories. Our reports are leading resources for industry professionals interested in molecular POC diagnostics, retail clinic diagnostics, and physician office laboratory (POL) markets worldwide.
- Display 45 Products per page
Published: April 23, 2024 | Price: $7,000.00 – $14,000.00
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: April 13, 2023 | Price: $6,000.00 – $12,000.00
The point-of-care diagnostics market has long been the opportunity market within IVD. Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters. While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area. There are more companies in the point of care market, and it is a top segment of investment. Now...Published: November 3, 2022 | Price: $6,000.00 – $12,000.00
Kalorama Information’s 11th Edition report of the clinical molecular testing industry provides marketing sizing and forecasts for in vitro diagnostics (IVDs) over a five-year period. In this report, our industry experts and top analysts assess the current positions of this complex market, which has an estimated value of more than $21 billion. This data publication has become an indispensable tool in clinical healthcare medicine and assesses the business opportunity, new product introductions, and rapid changes in several areas of this...Published: April 28, 2022 | Price: $6,000.00 – $12,000.00
As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: March 24, 2022 | Price: $5,000.00 – $10,000.00
The Market and Future Potential for Molecular Point of Care (POC), 2022 provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while...Published: June 17, 2021 | Price: $5,000.00 – $10,000.00
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...Published: April 13, 2021 | Price: $5,000.00 – $10,000.00
By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually. This should not be surprising. Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC COVID-19 was stunning. Updated for COVID-19 Impacts In some segments, COVID-19 caused a contraction of the segment...Published: January 22, 2021 | Price: $4,000.00 – $8,000.00
This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...Published: May 19, 2020 | Price: $5,000.00 – $10,000.00
Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...Published: April 7, 2020 | Price: $4,000.00 – $8,000.00
The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...Published: March 17, 2020 | Price: $5,500.00 – $11,000.00
This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: October 17, 2019 | Price: $5,000.00 – $10,000.00
Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the growing availability of HbA1c testing both at the professional level and at the self-testing level. Kalorama’s...Published: October 11, 2019 | Price: $5,000.00 – $10,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD...Published: June 6, 2019 | Price: $4,000.00 – $8,000.00
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: March 27, 2019 | Price: $5,000.00 – $10,000.00
Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics. Kalorama’s Worldwide Market...Published: February 22, 2019 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Molecular diagnostics performed at the point of care or near the patient is regarded as a leading expansion segment in the global in vitro diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the...Published: September 18, 2018 | Price: $3,500.00 – $7,990.00
IVD in Eastern Europe IVD companies continue to explore opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class. Eastern European markets are ripe for change. Many countries are engaging in healthcare reform programs to meet the growing demand for innovative products while containing costs in an increasingly...Published: September 14, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in VietnamThe IVD Market in Vietnam provides an overview of the in vitro diagnostics market in Vietnam and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in Vietnam, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious...Published: September 13, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in South Korea The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry,...Published: September 9, 2018 | Price: $5,000.00 – $10,000.00
Kalorama Information 2018 Regional IVD Market Bundle (IVD in China, The IVD Market in South Korea, The IVD Market in Vietnam) This Kalorama Information (KI) Market Research Bundle is a combination of 3 complete KI in vitro diagnostics (IVD) reports, including IVD in China, The IVD Market in South Korea and The IVD Market in Vietnam. The reports provide an overview of the IVD markets in China, South Korea and Vietnam. The revenue data provided give an overview of developments...Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...Published: April 10, 2018 | Price: $4,500.00 – $9,000.00
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology) Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in...Published: March 30, 2018 | Price: $3,995.00 – $7,990.00
What is The Market for Outsourced Manufacturing of IVD Products? Valued at more than $12 billion in 2017, the global OEM in vitro diagnostic (IVD) manufacturing segment is well positioned for long-term growth. Several trends and factors will boost the revenue potential of this business. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to expand product lines, broaden manufacturing capacity and capabilities, and serve selected customers. Contract IVD...Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: March 27, 2018 | Price: $995.00 – $1,990.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018. Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures...Published: March 22, 2018 | Price: $2,995.00 – $5,995.00
This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players. As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...Published: March 21, 2018 | Price: $1,500.00 – $3,000.00
This report provides market estimates and forecasts for point-of-care glucose testing. Information in this report is from the latest published figures for companies participating in the market as well as recent interviews. The following markets analysis is provided in this report: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level) POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW) Global POC Glucose Self-Testing Market (includes continuous glucose devices) ...Published: February 16, 2018 | Price: $3,995.00 – $7,990.00
What is the Size of the Point of Care Diagnostic Testing Market? This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will...Published: January 25, 2018 | Price: $3,995.00 – $7,900.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...Published: October 25, 2017 | Price: $3,600.00 – $7,200.00
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...Published: October 16, 2017 | Price: $3,600.00 – $7,200.00
Clinical Chemistry Markets (by Type [Instrument, Reagent], by Analyte [Glucose Market, Electrolytes Market, Cardiac Biomarkers Market, Enzymes Market, Proteins Market, Drugs of Abuse Market, Therapeutic Drugs Market, HbA1c Market, Other Commonly Tested Analytes] by Region) This Kalorama Information report, Clinical Chemistry Markets, examines the global market for clinical chemistry products and procedures. Among the products covered are instruments, reagents, and supporting consumables used worldwide in core laboratory and point-of-care (POC) medical testing. Clinical chemistry instruments consist of large multifunctional workstations...Published: October 12, 2017 | Price: $4,796.00 – $9,600.00
Published: October 5, 2017 | Price: $2,000.00 – $4,000.00
IVD Market Top 25 Companies: Revenue Performance, Products, Competitive Activity IVD Market Top 25 Companies presents advancements in in vitro diagnostics (IVD) by the Top 25 firms in the industry and provides an overview of the most recent trends and developments. Companies included are: Alere Inc. Arkray Beckman Coulter / Danaher Becton Dickinson Bio-Rad Laboratories bioMérieux Cepheid / Danaher Danaher Corp. (including Radiometer A/S) Grifols Hologic Illumina Instrumentation Laboratory / Werfen LabCorp, Laboratory Corporation of America Luminex Ortho Clinical Diagnostics...Published: September 6, 2017 | Price: $3,600.00 – $7,200.00
Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others) This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: Global Immunoassay Market, 2017-2021 Historical Market 2014-2016 ELISA Markets Radioimmunoassay Markets Lab-baded Immuonassay Markets POC Immumonassays Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease) Tumor Marker Immunoassays Thyroid Metabolic and Other Hormone Immunoassays Therapeutic Drug Monitoring Immunoassays Drugs of Abuse Immunoassays...Published: August 15, 2017 | Price: $200.00 – $400.00
Coverage of major IVD industry events and trends July 2017.Published: July 25, 2017 | Price: $2,800.00 – $5,600.00
Mexico IVD Market Analysis In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue data on the major market sub-segments for 2016-2021: In Vitro Diagnostic Sales by Market Segment (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose,...Published: July 19, 2017 | Price: $3,360.00 – $6,720.00
Indonesia IVD Market Analysis Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia's marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided: Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total) Microbiology (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies,...Published: May 4, 2017 | Price: $2,800.00 – $5,600.00
The POC market is considered evolving with growthopportunity.  Developing and developedmarkets alike have room to grow due to an aging population worldwide. Key companies such as Roche, LifeScan,Abbott, and Alere will likely maintain leading positions in the market throughcontinued product innovation and strategic alliances and mergers.  This report profiles 50 companies that will determine the future of POC testing, and also provides market sizing and forecast for: • The Global Point-of-Care Market, 2016-2021 • The Global POC Market by Testing...Published: February 3, 2017 | Price: $3,196.00 – $6,392.00
The World Market for Point of Care (POC) Diagnostics World Market for Point of Care (POC) Diagnostics examines the worldwide market for POC, including the following information: Worldwide POC Test Market for every significant segment of POC Testing from 2014-2021; Worldwide POC Market Share of top manufacturers, 2016; Professional and Self-testing, 2016; Worldwide POC professional testing analysis by product subcategory, 2016; POC testing revenues in US, Europe, Japan, and the rest of the world, 2016; POC market revenues for Germany,...